Briefing Materialfor 2nd quarter ended June 30, 2022

August 19, 2022
NAKANISHI INC.

Disclaimer
The information presented in these materials contains forward-looking statements about futurebusiness performance. These statements by definition involve risks and uncertainties and are
not intended to guarantee future performance. Actual results in the future may differ fromexpectations and the projections presented in these materials due to changes in the global
economy and fluctuations in foreign currency exchange rates and so on. NSKNSKNSKNSKNSKOverview of changes in reporting segments
Key changes

1. “Surgical Business” was separated from the previous reporting segment “Dental Products” andindividually established
2. Abolition of the previous reporting segment “Others (mainly included repair services)”, which will be
included in each new reporting segments

Previous reporting segments

New reporting segments
RenameDental Products

Dental BusinessSeparate

Surgical Business

RenameIndustrial Products

Industrial BusinessStarting from FY2022 Q1Development, production and sales ofwide range of dental equipment, which
cover such as restorative dentistry,
periodontics, mobile dental care, oral
surgery etc.
Development, production and sales ofbone grinding and cutting drills which canbe used in areas of neurosurgery, spine
surgery and orthopedic surgery.

Development, production and sales ofmotors and spindles which can be used inhigh-precision processes in wide range ofindustrial areas such as automobile,
aircraft, precision parts industries.

Others© 2022 NAKANISHI INC.

2

Product lineup
Dental business
Ti-Max Z Series Dental hand piece

Surgic Pro2 Oral surgery System

END-MATE DT2 Endodontic micromotor

Varios Combi Pro Oral hygiene system

iClave mini2 Autoclave

NLZ Clinical micromotor

VIVAace Mobile-dentistry unit

© 2022 NAKANISHI INC.

3

Product lineup
Industrial business

Surgical businessPrimado2 series

Total surgical system

Attachment

E4000 series

Motor & spindle

Emax EVOlution

Micro grinder

Bur

E3000 series

Motor & spindle

Sheenus ZERO

Ultrasonic polisher© 2022 NAKANISHI INC.

4

Contents

Consolidated financial result for FY2022Q2

P. 6

Consolidated financial forecast and dividend forecast for FY2022

P. 17

Mid Term Management Plan Rolling Plan “NV2025+”

P. 20

Overviews of Each Segment and Future Initiatives

P. 25© 2022 NAKANISHI INC.

5

Consolidated financial result for FY2022Q2

6

Performance highlights of FY2022Q1

The depreciation of the yen against major trading currencies boosted sales and profits.
Topline has been quite flat on YOY and local currency basis.

To keep our production level, we have been focusing on direct parts-purchasing frommarket (not from suppliers) and accelerating design changes as counter-measures toparts shortage. Forecast of parts procurement remains unstable.

We are taking intensive actions to expand production capacity to cover strong global
demand. New factory "A1+" is scheduled to start operation on September 5th.

© 2022 NAKANISHI INC.

7

Consolidated P/L
M of JPY

FY2022Q2

FY2021Q2

YoY

FY2022Q2

ActualActualComparison

Forecast

Net sales

24,46223,014+ 6.3 %

23,026+ 6.2 %

Gross profit

15,483

13,914+ 11.3 %13,917+ 11.3 %63.3 %

60.5 %+ 2.8 pt

60.4 %+ 2.9 pt

8,129

7,646

+ 6.3 %

6,546

+ 24.2 %33.2 %

33.2 %+ 0.0 pt

28.4 %+ 4.8 pt

9,490

7,423

+ 27.8 %7,095+ 33.7 %38.8 %

32.3 %+ 6.5 pt30.8 %+ 8.0 pt

6,750

5,366

+ 25.8 %5,062+ 33.4 %Ratio to net sales

27.6 %

23.3 %+ 4.3 pt

22.0 %+ 5.6 pt

(JPY)

78.52

61.93

123.16134.50107.74129.96

Ratio to net sales

Operating profit
Ratio to net sales

Ordinary profit
Ratio to net sales

Profit attributableto owners of parent

EPS

vs. FCST

58.75

Currency rate
- Against the US dollar

JPY- Against the EUROJPY

Forex impact: Net sales +1,290M of JPY
Forex sensitivity

vs FY2021Q2 Actual), +232M of JPY+ 15.42+ 4.54124.00131.00- 0.84
3.50

vs FY2022Q2Forecast

Fluctuation in annual net sales due to the depreciation of the yen (per one yen)
Against USD: Increase of 86M of JPY
Against EURO: Increase of 78M of JPY© 2022 NAKANISHI INC.

8

Net sales and OP profit
M of JPY

AmountNet sales
25,00023,014

24,462Composition ratio

23,014

Net sales

Net sales
YoY

24,462
COGS%
YoY

100%

+1,447+6.3%

20,000

COGS

9,099

8,978

-2.8 pt90%

Excluding the forex impact,
net sales remained flat year
on year

80%

39.5%

36.7%

27.2%

30.1%

Impact of higher parts
prices were offset bystronger trading currencies

70%

15,00060%

SGA
10,000

6,267

7,353

50%

SGA%
40%

OP
YoY

SGA%
YoY

30%

+482

5,000

7,646

OP

8,129

+6.3%

20%

OP margin

The depreciation of yen
boosted profits

0

FY2021Q2
ActualFY2022Q2
Actual© 2022 NAKANISHI INC.

+2.8 pt

33.2%

33.2%

FY2021Q2
ActualFY2022Q2
Actual10%0%Normalized marketing
activities resulted inhigher SGA%

9

Change in net sales by business segment
M of JPY+ 1,447
14,000+ 6.3%FY2021Q2
ActualFY2022Q2
ActualChangeDental19,872

20,530+3.3%

Surgical

1,351

1,681

+24.4%

Industrial

1,790

2,250

+25.7%

23,014

24,462+6.3%

13,50024,462
13,000+459
12,50012,00023,014+658+329

Industrial

Surgical+25.7%+24.4%

11,500Dental+3.3%

11,00010,500Total

10,0009,500

Forex impact

9,000

FY2021Q2
Actual+1,290M of JPY +5.6%

FY2022Q2
Actual© 2022 NAKANISHI INC.

10

Change in net sales by region
M of JPY+ 1,447+ 6.3%FY2021Q2
ActualFY2022Q2
ActualChange

Japan

5,606

4,416

-21.2%

Europe

6,859

7,740

+12.8%

N. America

3,839

5,473

+42.5%

Asia

3,697

3,475

-6.0%

Others

3,010

3,355

+11.5%

Total

23,014

24,462+6.3%

14,00024,462

-221

+345

Asia
-6.0%

Others+11.5%

13,00012,000+1,63323,014-1,19011,000Japan-21.2%

10,000+880

N. America+42.5%

Europe+12.8%

9,000

Forex impact

8,000

FY2021Q2
Actual+1,290M of JPY +5.6%

FY2022Q2
Actual© 2022 NAKANISHI INC.

11

Change in operating profit by segment
M of JPY+ 482+ 6.3%

4,500

+113

4,300

+230

Industrial+17.3%

-79

3,900

7,646

Corporate
expenses

Surgical+35.2%

Dental
+2.6%

3,700

FY2022Q2
ActualChangeDental

8,452

8,669

+2.6%

Surgical654

885+35.2%

Industrial

660

774

+17.3%

Corporate
expenses-2,120-2,199

Total

7,646

8,129

8,129

4,100

+217

FY2021Q2
Actual

+6.3%

3,500

Forex impact

3,300

FY2021Q2
OP profit+1,290M of JPY +5.6%

FY2022Q2
OP profit© 2022 NAKANISHI INC.

12

Change in operating profit
M of JPY
2021/06 Average

+ 482

3,700

USD

107.74 JPY→

123.16 JPY

EURO

129.96 JPY→

134.50 JPY+ 6.3%

4,200

7,646

+ 95
Increasein demand

3,200

+ 183
Product mix

2022/06 Average

8,129

-338
+ 1,014-119

Increase in
selling expenses Increase inpersonnel
expenses-352
Increase inForex impact
other expenses

2,700

Based on forex as of 2021Q2
2,200

FY2021Q2
OP profit

FY2022Q2
OP profit© 2022 NAKANISHI INC.

13

OP profit and profit attributable to owners of parent
M of JPY

8,129

Operating profit

1,694

Non-operating profit

334

Non-operating expenses

Ordinary profit

9,490

Extraordinary income

65
33

Extraordinary losses

9,522

Profit before income taxes

Non-operating
profitForeign exchange gain

1480

Non-operating
expenses

Loss on investments inmoney held in trust

248

Extraordinary
incomeGain on sales of non-current assets 65

Extraordinary
lossesLoss on sales of non-current assets 31

2,770

Total income taxes
Profit attributableto owners of parent

6,750
300

1,300

2,300

3,300

4,300

5,300

© 2022 NAKANISHI INC.

6,300

14

Consolidated balance sheet
M of JPY

As of June 30,

As of Dec. 31,

2022

2021

98,914

94,460+4,453

6,284

5,348

+936

Total asssets- Notes and accounts receivable - trade

Cash and deposits
Construction in progress

-15
+844

- Inventories

13,232

11,733+1,499Merchandise and finished goods +95
Work in process+476
Raw materials and supplies+926

Liabilities

9,748

11,541-1,792

Account payable - trade
Provision for bonuses
Other current liabilities

100

100

―

89,16582,919+6,245- Retained earnings

89,792

84,765+5,027Return on equity (ROE)

11.2 %

12.7 %-1.5 pt

Return on assets (ROA)

13.9 %

15.8 %-1.9 pt

FY2022Q2
ActualFY2021Q2
ActualChange1,701

575+1,126

918

853

+65

- Loans payable

Net assets

+403
-471
-1,747

ROE and ROA are calculated based on the FY2022 forecast..

Capital investments
Depreciation expenses© 2022 NAKANISHI INC.

Note
New factory “A1+”Information system

625
239

15

M of JPY
25,00023,000Cash flows fromoperating activities

Cash flows frominvesting activities+2,805-3,363

Cash flows fromfinancing activities

Effect of exchange
rate change

21,00019,00034,87733,89417,00015,00013,000

Profit before
income taxes+9,522

Depreciation+918

Income taxes paid

-2,900Foreign exchange
gains-2,605Purchase ofnon-current assets-1,741

Purchase of shares ofsubsidiaries andassociates-1,56811,000-2,800+2,365

Dividends paid

-1,722

Purchase oftreasury shares-1,077

Free cash flows

9,000

-558
7,000

5,000

Cash and cash equivalents at
beginning of period

Cash and cash equivalents at
end of period© 2022 NAKANISHI INC.

16

Consolidated financial forecast
and dividend forecast for FY2022

17

Financial forecast for FY2022
M of JPY

FY2021

FY2022

ActualForecast

AmountRatio

Net sales

44,85745,788+931+2.1 %

Gross profit

27,29527,723+428+1.6 %

60.8 %

60.5 %-0.3 pt

13,75012,606-1,14330.7 %

27.5%-3.1 pt

13,951

13,587-364

31.1 %

29.7 %-1.4 pt

10,102

9,621

-481

Ratio to net sales

22.5 %

21.0 %-1.5 pt

JPY

116.73111.66——- Against the US dollar

JPY

109.84124.00+14.16—- Against the EUROJPY

130.08131.00+0.92—

Ratio to net sales

Operating profit
Ratio to net sales

Ordinary profit
Ratio to net sales

Profit attributable toowners of parent© 2022 NAKANISHI INC.

YoY Comparison
Note-8.3 %-2.6 %-4.8 %

18

Dividend forecast for FY2022
Payout policy
We believe the return of profits to our shareholders as one of the important management issues. Key issue is the balance to enhance businessstructure, promote investment in growth areas properly and to return profits to shareholders.
Our policy is to keep stable and continuous growth in dividend and buy back shares flexibly. We will realize total payout ratio 50% in this mid-termplan through the policy in parallel to keep necessary retained earnings for future growth.

Transition of shareholder return10

3-for-1 stock split in April 2018
60. 0%

2017

Total amount of treasury stock acquisition (B of JPY)

9

Total annual dividend (B of JPY)

8

Total payout ratio

7

40.3%

6
5

35.4%

36.6%

2020

2021

2022

ActualActualActualForecast

26.00

31.00

30.00

30.00

37.00

44.00

Payout ratio

30.7

35.4

36.6

40.3

31.7

39.2

Total payout ratio

30.7

35.4

36.6

40.3

43.5

−

Feb. 2022
ActualMar. 2022
Actual

May 2022
ActualJun. 2022
ActualJul. 2022
Actual

92,200 145,500

92,200JPY

40. 0%

Treasury stockacquisition

30.7%

4

1.4 B JPY
30. 0%

0.1

3

0.1

1.1

Annual dividends

2
1

2019

ActualAnnual dividends

50. 0%

43.5%

2018

Actual

3.7 B JPY
20. 0%

2.2

2.6

2.5

2.5

3.1

Total number of
Sharesshares repurchased

087,900 153,700

10. 0%

2017

2018

2019

2020

2021

2022

Repurchase costs

M JPY

179

320

213

363

222

Forecast© 2022 NAKANISHI INC.

19

Mid Term Management Plan Rolling Plan

NV2025+

Background of Formulation of Rolling Plan NV2025+
Global share increasing further since the COVID-19 outbreakatest performance results are above plans
Yen weakening against almost all transaction currencies
ignificant changes to performance target assumptions

Mid Term Management Plan Rolling Plan

NV2025+
1. No changes to the policy and strategy set out in the previous plan NV2025
2. Sales and profit targets updated based on latest performance results andexchange rates
3. Established new KPIs such as ROE and cash allocation© 2022 NAKANISHI INC.

21

Establishment of Additional KPIs
In Rolling Plan NV2025+, in addition to updating the sales and profit target sets in the previous
plan NV2025, we have added a “capital efficiency indicator” and a “cash allocation indicator” tomake our PL, BS, and CFS management policy clearer

Evolve from PL-oriented management to one that also prioritizes capitalefficiency at the same time
Allocate cash by considering the balance of growth investments, shareholder
returns, and resilience to risk
Previous plan

NV2025

Rolling Plan

Net sales

Operating profit Operating margin

50.0 B JPY 14.0 B JPY

Net sales

28 %Cash & marketable

Operating profit Operating margin

NV2025+ 55.0B JPY 16.5 B JPY

30

ROE

+

© 2022 NAKANISHI INC.

11

Total payout ratio+

50

securities to monthly+

sales ratio

1222

NV2025+ Sales and Profit Target
Net sales: 55.0 B JPY +10% over previous plan
Operating profit: 16.5 B JPY +18% over previous plan
Operating margin: 30% +2pts over previous plan

60.0

Net sales
55.0 B 30.0
JPY

50.0

25.0

Net sales (Left)

44.8

Operating profit (Right)

Operatingprofit16.5 B
JPY

40.0

13.7

30.0

20.0

15.0

20.0

10.0

10.0

5.0

0.0

0.0

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Assumed exchange rates for 2022 to 2025: 1USD=124JPY; 1EURO=131JPY© 2022 NAKANISHI INC.

23

Factor Analysis of Changes to Sales and Profit Targets
Changes to Top Line

Changes to Profit Structure

Revised exchange rate assumptions on which to base sales target
Reflected market growth realized after the COVID-19 outbreak
Reflected the effects of delays in new product development

No significant changes to profit structure (composition)
Reflected the effects of sales increases and weaker yen* As we have prioritized measures to meet Medical Device Regulations (MDR) as well
as design changes and other initiatives to prevent production disruptions due to parts
supply shortages, new product development has been delayed.

+5.0 B JPY (+10%)[Net sales]

44.8 B
JPY

50.0 BJPY

55.0 B
JPY

39%

40%

38%

30%

32%

32%

31%

28%

30%

ActualFY2021

Previous plan
NV2025

Rolling Plan
NV2025+

140

100%

120

+4.0

100

80

60

50.0 BJPY

55.0 B
-2.0
JPY

20

[Cost of sales] 80%
70%

Delayednew productlaunches

+3.0

60%

Marketgrowth after
COVID-19
outbreak50%[Selling, generaland administrative40%
expenses]

30%

Revisedexchange
rage
assumptions

40

90%

[Operating
profit]

20%

10%

0%

0

Previous plan
NV2025

Rolling Plan
NV2025+© 2022 NAKANISHI INC.

24

Overviews of Each Segment
and Future Initiatives

25Transition of Net Sales

Net sales has been flat on YOY basis without FOREX impact.

6,000

Q1

Q2

119.8

124.8

6.4

8.0

Q3

Q4

5,000

FY20224,000
FY20213,000

FY2020
2,000

1,000
1

2

3

4

5

6

7

© 2022 NAKANISHI INC.

8

9

10

11

12
26

Global Trend of Net Sales

Europe7.7 B JPY

YoY +0.8 B JPY+12.8

DentalIndustrial

SurgicalN. America

Japan

Asia

4.4 B JPY

YoY -1.1 B JPY-21.2

DentalIndustrial

Surgical

3.4 B JPY

YoY +1.6 B JPY+42.5

DentalIndustrial

SurgicalSouth America, Russia, Middle East, Australia, etc.

OthersYoY -0.2 B JPY-6.0

DentalIndustrial➞

Surgical

5.4 B JPY

YoY +0.3 B JPY
Dental© 2022 NAKANISHI INC.

3.3 B JPY
+11.5

Surgical➞ Industrial

27

Mid Term Management Plan Rolling Plan NV2025+

Formulated Mid Term Management Plan Rolling Plan based onlatest performance results and exchange rate trends
Mid Term Management Plan Rolling Plan

NV2025+Progress in FY2022

Basic Policy and Priority Measures

1. Strategic expansion in Dental
global market

1. Performance results for first half
reached a record high

2. Growing new business forcustomer needs in super
population ageing

2. Significant increase in sales andshare in the U.S. market

3. Establish infrastructure forspeedy product development
and leading cost competitiveness3. New factory ”A1+” completed on
September 5
4. Decided to build a new factory “M1”

Turn the COVID-19 pandemic into an opportunity to expand business scale.
Promote initiatives to increase production.
© 2022 NAKANISHI INC.

28

New parts processing plant “A1+”A1
A1
New plant

A1

New parts processing plant

To transform production operations to ones able toeffectively meet globally growing product demand,
aim to increase “parts processing” capacitythat was previously a bottleneck

Location: 990 Fukahodo, Kanuma, Tochigi(on the premises of the A1 plant)
Total floor area: Approx. 5,500 m2
Investment: Approx. 1.8 billion yen

Completion on September 5 (Scheduled)© 2022 NAKANISHI INC.

29

New assembly plant “M1”

M1
Headquarter R&D Center RD1

New plant

New assembly plantand parts and finished goods warehouse

Determined to construct a new plant to increase capacity
for the “assembly process” following the parts processing
process that we are working to expand, and secure warehouse
space to respond to production scale expansion

M1

Location: 700 Shimohinata, Kanuma, Tochigi(in the premises of Headquarters)
Total floor area: Approx. 17,500 m2
Investment: Approx. 6.2 billion yen
Operation Start: First phase: March 2024 (scheduled);
Second phase: December 2024 (scheduled)© 2022 NAKANISHI INC.

30

Basic Strategy for 2022

Forecast of market trends in 2022
Global demand continues toincrease since the COVID-19
outbreakContinued challenges in procuring
semiconductors, electronic
components, etc.

Basic Strategy for 2022 (Revised)
Maximize production to capture strong global demand to
the fullest extent possible
Avoid production cutbacks through flexible parts procurement and design changes
Aim for early launch of construction of new factory “A1+”© 2022 NAKANISHI INC.

31

Dental Business Outline 1/3

Overview of 1st half

Sales trend

Steady sales of our main
products, handpieces andimplant motors.
Ongoing strong sales in the U.K.,
where we have attracted somedental colleges.

EuropeYoY

Sales trendJapan

NSK Dental Nordic, our base in
Nordic area, is making a goodstart in business.

With the termination of
government subsidies in Marchlast year, demand peaked out
and sales declined sharply.

Outlook for 2nd halfSales
outlook

Expand sales ofhandpieces and implant
motors.

YoY

Start full-fledged sales
activities for NSK Dental
Nordic, aiming for a large
increase in sales.

Sales
outlookOEM business remained strong.
YoY

YoY

© 2022 NAKANISHI INC.

Recovery in sales is
expected after exiting thephase of reactionary
decline in demand.
Expand sales ofhandpieces and implant
motors.

32

Dental Business Outline 2/3

Overview of 1st half

Sales trend

North
America
YoY

Sales trend

Sales increased significantly
due to growth in our main
products, handpieces andmicromotors.

Steady OEM sales also
contributed to increase in sales.

In China, sales declined due toa lockdown that halted productshipments for about 2.5 months.
Sales to South Korea were on apar with the same period of theprevious year.

Asia
YoY

Sales to Southeast Asian
countries recovered.
© 2022 NAKANISHI INC.

Outlook for 2nd halfSales
outlook

YoY

Despite concerns about
economic recession,
expand sales of contra
angles and micromotors,
in which we have a strong
product advantage.
Continue approaches todental colleges and DSO.

Sales
outlook

Demand in China returns
to normal following thelifting of lockdown. Aim
to catch up in performance.
Start to respond to Buy
China policy.

YoY

Sales to South Korea andSoutheast Asian countries
are expected to decline
slightly.
33

Dental Business Outline 3/3

Overview of 1st half

Outlook for 2nd half

Sales growth by steadily
capturing rebound demand
from the COVID-19 pandemic.

Middle
East

YoY

YoY

South
America
YoY

Strong sales due partly tocompetitors’ withdrawal frombusiness in South America.
Market share expanded.

Expand sales of our main
products, handpieces andimplant motors.
YoY

YoY

Assume that logistics
delays and other disruptions
continue for the time being
due to the prolonged
invasion of Ukraine.

YoY

Expand sales of handpieces
and implant motors under
the assumption of levelingdemand.

Sales to Russia and CIS
counties dropped sharply due
to the invasion of Ukraine.

RussiaYoY

Sales to Australia and Oceania
remained strong.

Australia
YoY© 2022 NAKANISHI INC.

Continue to respond toincreasingly active
bidding for governmental
hospitals, university
hospitals, etc.

34

Dental Business Topics

Exhibiting at Dental Trade Show around the world

2022/01/27～

2022/03/17～

Yankee Dental
Congress

ADX Sydney
Australia

U.S.

2022/02/01～

2022/05/19～

AEEDC Dubai

Expodental
Meeting Rimini

UAE

Italy

© 2022 NAKANISHI INC.

35

Overview of 1st half
Sales grew due to successful sales activities and sales promotion campaigns in line with the periodthat demand was recovering
YoY

Japan

Sales grew due to successful sales activities to spine surgery in addition to the existingneurosurgery.

YoY

EuropeSales grew as a result of steadily winning renewal projects from existing customers and largescale projects from major hospitals in the region.

YoY

North
AmericaOur product “Primado2” is highly evaluated, and together with alliances with partners, achieved
a significant increase in sales.

YoY

Asia

Despite a smooth start at the beginning of the period, sales declined due to the impact of the
lockdown in China.

Outlook for 2nd half
Launch and expand the sales of our new product “P300AT” in North America on a full scale.
Promote measures to expand sales channels.
YoY

Japan

Accelerate sales promotion activities in the otology field to further enhance the customer base.

YoY

EuropeContinue sales approach to major hospitals and focus on winning contracts for large-scaleinquiries.

YoY

North
America

Expand sales of our new product “P300AT” and focus on expanding sales channels leveraging
an alliance with partners.

YoY

Asia

Accelerate sales promotion activities in response to the lifting of the lockdown in China and thelifting of movement restrictions in Asian countries.
© 2022 NAKANISHI INC.

36

Surgical Business Topics

Enhance customer contact through resumed conferences andhands-on courses both in Japan and abroad

Electric bone cutting drill thatcan be used in neuro,orthopedic, and spine surgeries,
etc.

ConsoleAttachment “P300AT”

Hands-on course at the 42nd Annual Meeting of theJapanese Congress of Neurological Surgeons© 2022 NAKANISHI INC.

Disposable “QuadEdge bur”

“Primado2” series products
37

Industrial Business Outline

Overview of 1st half
Achieved a significant increase in sales as a result of fulfilling orders received which we
captured to the maximum extent possible against a backdrop of growing global demand
YoY

Japan

Steady sales of spindles for high-precision processing field such as deburring, drilling, andsubstrate partitioning.

YoY

EuropeSales increased due to fulfillment of orders received from the previous year. Inquiries at theresumed exhibitions were also brisk.

YoY

North
America

Capital investment motivation remained strong, and sales, especially of spindles, grew
substantially.

YoY

Asia

Despite brisk demand, sales remained flat as controller production could not keep up withdemand due to component shortages.

Outlook for 2nd halfContinue production efforts to ensure delivery of orders while capturing firm capital investment
demand to the fullest extent possible
YoY

Japan

Field many inquiries from a wide range of industries. Focus on acquiring new projects, including
those through an alliance with partners.

YoY

EuropeThere are signs of a lull in demand. Aim to uncover potential demand by appealing applicationcase studies.

YoY

North To establish a strong business foundation, strengthen the sales structure of local subsidiaries andAmerica expand the dealer network.

YoY

Asia

Continue to develop the dealer network while steadily winning capital investment projects, anarea seeing high demand.
© 2022 NAKANISHI INC.

38

Industrial Business Topics
June 22 to 24, 2022 at Tokyo Big Sight

Participated in Manufacturing World Japan 2022

Participated in a large-scale exhibition for the first time in three years.
Enhanced presence by exhibiting in a booth facing the main aisle.
© 2022 NAKANISHI INC.

39

We have issued "Sustainability Report 2022”.
Please refer to our ESG initiatives.

https://en.nakanishi-inc.jp/sustainability_report/© 2022 NAKANISHI INC.

40